UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure

Opticyte, which got its start at the University of Washington, received $4.6 million from federal grants and seed funding to continue developing a non-invasive technology that can detect oxygen levels in cells in real time. Opticyte’s Cell O₂ Monitor will allow doctors to rapidly assess a patient’s cell oxygen levels, cutting down on the time it traditionally takes and allowing providers to more quickly address sepsis and improve patient outcomes.